| pubmed-article:19726412 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19726412 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19726412 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:19726412 | lifeskim:mentions | umls-concept:C1947952 | lld:lifeskim |
| pubmed-article:19726412 | lifeskim:mentions | umls-concept:C0560013 | lld:lifeskim |
| pubmed-article:19726412 | lifeskim:mentions | umls-concept:C1314939 | lld:lifeskim |
| pubmed-article:19726412 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:19726412 | pubmed:dateCreated | 2010-6-4 | lld:pubmed |
| pubmed-article:19726412 | pubmed:abstractText | Reactivity against terminal NeuNAc(alpha2-3)Gal, common to several gangliosides such as GD1a, GT1b and GM3, has rarely been reported. The authors recently described a patient with a clinical picture of acute relapsing sensory ataxic neuropathy and bulbar involvement in whom they demonstrated concomitant reactivity against NeuNAc(alpha2-3)Gal and disialosyl epitopes. The authors suggested a correlation between NeuNAc(alpha2-3)Gal reactivity and bulbar involvement. | lld:pubmed |
| pubmed-article:19726412 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19726412 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19726412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19726412 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19726412 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:19726412 | pubmed:issn | 1468-330X | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:GallardoEduar... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:De LunaNoemiN | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:IllaIsabelI | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:JuarezCandido... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:CarvajalAleja... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:FagesEvaE | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:Rojas-GarciaR... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:Martinez-Hern... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:CasasnovasCar... | lld:pubmed |
| pubmed-article:19726412 | pubmed:author | pubmed-author:Davila-Gonzál... | lld:pubmed |
| pubmed-article:19726412 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19726412 | pubmed:volume | 81 | lld:pubmed |
| pubmed-article:19726412 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19726412 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19726412 | pubmed:pagination | 623-8 | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:meshHeading | pubmed-meshheading:19726412... | lld:pubmed |
| pubmed-article:19726412 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:19726412 | pubmed:articleTitle | Bulbar involvement in patients with antiganglioside antibodies against NeuNAc(alpha2-3)Gal. | lld:pubmed |
| pubmed-article:19726412 | pubmed:affiliation | Department of Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. rrojas@santpau.cat | lld:pubmed |
| pubmed-article:19726412 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19726412 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
